As a progressive freshman mayor, Johnson’s challenge now is to stand up for Chicago’s large immigrant community while also navigating the risks of antagonizing Trump.

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Johnson can keep the GOP united by proposing a bill ending every Democrat-supported malady at once.

We recently published a list of Jim Cramer Discusses TikTok Ban, President Trump & These 6 Stocks. In this article, we are ...

A new Wall Street Journal report says there are a few reasons why a company might list a job, but never follow through and hire someone.

Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.

Dueling moves by Trump and Biden open new frontiers for one of the most sweeping powers in the Constitution.

We recently compiled a list of the Billionaire Prem Watsa’s Top 15 Long-Term Stock Picks. In this article, we are going to ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...

Loss of breadth: Check. A handful of technology giants-what UBS calls the 'Magnificent Six,' which excludes Tesla -are driving the market, while smaller stocks lag. The average 12-month forward ...

Johnson & Johnson (NYSE: JNJ) is an elite dividend stock. The healthcare giant has increased its dividend payment for 62 ...

Wall Street's indexes rose on Wednesday, with the benchmark S&P 500 hitting an intraday record high as investors cheered streaming video provider Netflix's quarterly report and President Donald ...